substance p has been researched along with Osteoarthritis in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.04) | 18.7374 |
| 1990's | 12 (24.49) | 18.2507 |
| 2000's | 13 (26.53) | 29.6817 |
| 2010's | 16 (32.65) | 24.3611 |
| 2020's | 7 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, RJ; Eitner, A; Grässel, S; Johnstone, B; König, M; Stöckl, S | 1 |
| Adachi, N; Ishikawa, M; Kanemitsu, M; Miyaki, S; Nakasa, T; Nekomoto, A; Shirakawa, Y; Yimiti, D | 1 |
| Ahn, W; Han, SH; Jung, BS; Kim, DK; Kim, IS; Ko, KR; Lee, H; Lee, S | 1 |
| Beaudry, F; Bédard, A; Bouet, E; Delsart, A; Frezier, M; Gaumond, I; Guillot, M; Keita-Alassane, S; Lecomte, R; Lussier, B; Marchand, S; Martel-Pelletier, J; Moreau, M; Otis, C; Pelletier, JP; Troncy, E | 1 |
| Adachi, N; Ikuta, Y; Ishikawa, M; Miyaki, S; Nakasa, T; Nekomoto, A; Shirakawa, Y; Tokumoto, M | 1 |
| Jain, M; Joharapurkar, A; Patel, V | 1 |
| He, J; Zheng, S | 1 |
| Chen, YJ; Greenhill, C; Ivanusic, JJ; Kim, DH; Nencini, S; Ringuet, M | 1 |
| Heikkilä, HM; Hielm-Björkman, AK; Innes, JF; Laitinen-Vapaavuori, OM | 1 |
| Kashiwakura, JI; Kuroda, K; Mishima, S; Okamura, Y; Okayama, Y; Saito, S; Sasaki-Sakamoto, T; Tokuhashi, Y; Toyoshima, S | 1 |
| Grässel, S; Muschter, D | 1 |
| Beaudry, F; Guillot, M; Martel-Pelletier, J; Moreau, M; Otis, C; Pelletier, JP; Troncy, E | 1 |
| Frallonardo, P; Lorenzin, MG; Oliviero, F; Ortolan, A; Punzi, L; Ramonda, R; Scanu, A | 1 |
| Beaudry, F; Bertaim, T; Del Castillo, JR; Gauvin, D; Martel-Pelletier, J; Moreau, M; Otis, C; Pelletier, JP; Rialland, P; Troncy, E | 1 |
| Matsuo, S; Murakami, K; Nakagawa, H; Nishimura, K | 1 |
| Lisowska, B; Lisowski, A; Siewruk, K | 1 |
| Jeon, SJ; Jung, Y; Kim, JE; Kim, SH; Kim, SJ | 1 |
| Chen, J; Li, Z; Liu, Y; Wang, B; Wang, X; Xiao, J; Yu, W | 1 |
| Bobrik, V; Fassold, A; Grifka, J; Kessler, S; Koeck, FX; Straub, RH | 1 |
| Flood, J | 1 |
| Beaudry, F; Ferland, CE; Pailleux, F; Vachon, P | 1 |
| Ahmed, AS; Ahmed, M; Bakalkin, G; Erlandsson-Harris, H; Li, J; Stark, A | 1 |
| Vilensky, JA; Witt, KL | 1 |
| Beaudry, F; Ferland, CE; Vachon, P | 1 |
| Kaneyama, K; Miyamaru, M; Nishimura, M; Segami, N; Suzuki, T | 1 |
| de Miguel, E; Hernanz, A; Martín-Mola, E; Medina, S | 1 |
| Ordeberg, G | 1 |
| Cheng, TO | 1 |
| Fujimura, K; Kaneyama, K; Nagao, T; Sato, J; Segami, N; Yoshimura, H | 1 |
| Davis, F; Ellman, M; Forsyth, CB; Im, HJ; Kim, GH; Li, X; Muddasani, P; Rangan, J; Thonar, EJ | 1 |
| Arnalich, F; de Miguel, E; Gijon-Banos, J; Hernanz, A; Martinez, M; Perez-Ayala, C; Vazquez, JJ | 1 |
| Alstergren, P; Appelgren, A; Appelgren, B; Kopp, S; Lundeberg, T; Theodorsson, E | 1 |
| Arnalich, F; De Miguel, E; Gijon, J; Hernanz, A; Perez-Ayala, C; Romera, N | 1 |
| Bruxelle, J; Cesselin, F; Laoussadi, S; Mauborgne, A; Menkes, CJ; Renoux, M | 1 |
| Pritchett, JW | 1 |
| Fortier, LA; Nixon, AJ | 1 |
| Iannone, F; Lapadula, G | 1 |
| Cook, JA; Vilensky, JA | 1 |
| Agarwal, RK; Chandna, VK; Kirker-Head, CA; Kumar, MS; Morris, EA; O'Callaghan, MW; Rand, W; Tidwell, A | 1 |
| Creamer, P | 1 |
| Jüsten, HP; Miller, LE; Schölmerich, J; Straub, RH | 1 |
| Hirabayashi, K; Inoue, H; Kajigaya, H; Koshihara, Y; Oda, H; Shimoyama, Y; Yamamoto, S | 1 |
| Goss, AN; Tahmasebi-Sarvestani, A; Tedman, R | 1 |
| Grifka, J; Miller, LE; Schölmerich, J; Straub, RH | 1 |
| Chiu, B; Inman, RD; Marshall, KW | 1 |
| Matucci-Cerinic, M; Partsch, G | 1 |
| Ekblom, A; Hansson, P; Holmlund, A; Lind, J; Lundeberg, T; Theodorsson, E | 1 |
| Cagnoni, M; Del Bianco, E; Geppetti, P; Marabini, S; Marchesoni, A; Matucci-Cerinic, M; Partsch, G; Tosi, S | 1 |
| Badalamente, MA; Cherney, SB | 1 |
9 review(s) available for substance p and Osteoarthritis
| Article | Year |
|---|---|
Substance P, A Promising Therapeutic Target in Musculoskeletal Disorders.
Topics: Humans; Musculoskeletal Diseases; Neurokinin-1 Receptor Antagonists; Osteoarthritis; Receptors, Neurokinin-1; Substance P | 2022 |
Therapeutic Potential of Diacerein in Management of Pain.
Topics: Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cytokines; Glutamates; Histamine; Humans; Matrix Metalloproteinases; Nitric Oxide; Osteoarthritis; Pain; Prostaglandins; Substance P; Transient Receptor Potential Channels | 2022 |
Peripheral Nerve Fibers and Their Neurotransmitters in Osteoarthritis Pathology.
Topics: Calcitonin Gene-Related Peptide; Chondrocytes; Humans; Neuropeptides; Neurotransmitter Agents; Osteoarthritis; Peripheral Nerves; Receptors, Adrenergic; Substance P; Vasoactive Intestinal Peptide | 2017 |
Pain and microcrystalline arthritis.
Topics: Animals; Arthritis, Gouty; Calcium Pyrophosphate; Chronic Pain; Crystallization; Dinoprostone; Disease Models, Animal; Humans; Inflammation Mediators; Interleukin-1beta; Kinins; Musculoskeletal Pain; Nociceptors; Osteoarthritis; Quality of Life; Rats; Substance P; TRPV Cation Channels; Uric Acid | 2014 |
The role of acetaminophen in the treatment of osteoarthritis.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Endorphin; Humans; Nitric Oxide; Osteoarthritis; Substance P | 2010 |
The anatomy of osteoarthritic joint pain.
Topics: Calcitonin Gene-Related Peptide; Humans; Joints; Nociception; Nociceptive Pain; Osteoarthritis; Substance P | 2014 |
Characterization of joint pain in human OA.
Topics: Arthralgia; Humans; Hyperalgesia; Nociceptors; Osteoarthritis; Pain Threshold; Peripheral Nervous System Diseases; Substance P | 2004 |
Neurogenic acceleration of osteoarthritis.
Topics: Animals; Autonomic Nervous System; Calcitonin Gene-Related Peptide; Capsaicin; Diabetes Mellitus, Experimental; Electrophysiology; Humans; Nervous System; Neuropeptides; Osteoarthritis; Proprioception; Substance P | 1998 |
Osteoarthritis pain and its treatment.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Arthroplasty, Replacement; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Exercise Therapy; Glucosamine; Humans; Isoenzymes; Membrane Proteins; Nitric Oxide; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Substance P | 2000 |
1 trial(s) available for substance p and Osteoarthritis
| Article | Year |
|---|---|
The effect of intra-articular botulinum toxin A on substance P, prostaglandin E
Topics: Animals; Arthralgia; Botulinum Toxins, Type A; Dinoprostone; Dog Diseases; Dogs; Double-Blind Method; Female; Injections, Intra-Articular; Male; Osteoarthritis; Pain; Pain Management; Substance P; Synovial Fluid; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
39 other study(ies) available for substance p and Osteoarthritis
| Article | Year |
|---|---|
Substance P and Alpha-Calcitonin Gene-Related Peptide Differentially Affect Human Osteoarthritic and Healthy Chondrocytes.
Topics: Aged; Apoptosis; Calcitonin Gene-Related Peptide; Cartilage, Articular; Cells, Cultured; Chondrocytes; Female; Humans; Male; Middle Aged; Osteoarthritis; Signal Transduction; Substance P | 2021 |
Therapeutic effect of targeting Substance P on the progression of osteoarthritis.
Topics: Animals; Aprepitant; Cartilage, Articular; Disease Models, Animal; Humans; Mice; Osteoarthritis; Phosphates; Substance P; X-Ray Microtomography | 2022 |
Estrogenic impregnation alters pain expression: analysis through functional neuropeptidomics in a surgical rat model of osteoarthritis.
Topics: Animals; Calcitonin Gene-Related Peptide; Estradiol; Female; Osteoarthritis; Pain; Prospective Studies; Rats; Rats, Sprague-Dawley; Substance P | 2022 |
The role of substance P on maintaining ligament homeostasis by inhibiting endochondral ossification during osteoarthritis progression.
Topics: Animals; Cartilage, Articular; Chondrocytes; Homeostasis; Humans; Matrix Metalloproteinase 13; Mice; Osteoarthritis; Osteogenesis; Posterior Cruciate Ligament; Substance P | 2023 |
NF-κB Phosphorylation Inhibition Prevents Articular Cartilage Degradation in Osteoarthritis Rats via 2-Aminoquinoline.
Topics: Aminoquinolines; Animals; Cartilage, Articular; Cytokines; Dinoprostone; Edema; Extremities; Joints; Male; Matrix Metalloproteinase 13; NF-kappa B; Osteoarthritis; Phosphorylation; Rats, Wistar; Receptors, Purinergic P2X7; Signal Transduction; Substance P | 2020 |
Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain.
Topics: Action Potentials; Animals; Antibodies; Bone and Bones; Calcitonin Gene-Related Peptide; Disease Models, Animal; Freund's Adjuvant; Male; NAV1.8 Voltage-Gated Sodium Channel; NAV1.9 Voltage-Gated Sodium Channel; Nerve Growth Factor; Nociceptors; Osteoarthritis; Pain; Rats; Rats, Sprague-Dawley; Signal Transduction; Substance P; TRPV Cation Channels; Ubiquitin Thiolesterase | 2017 |
The dual regulation of substance P-mediated inflammation via human synovial mast cells in rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Biomarkers; Cells, Cultured; Cytokines; Female; Fluorescent Antibody Technique; Gene Expression; Humans; Inflammation Mediators; Male; Mast Cells; Middle Aged; Osteoarthritis; RNA, Messenger; Substance P; Synoviocytes | 2017 |
Spinal neuropeptide modulation, functional assessment and cartilage lesions in a monosodium iodoacetate rat model of osteoarthritis.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Cartilage Diseases; Disease Models, Animal; Female; Iodoacetic Acid; Neuropeptides; Nociception; Osteoarthritis; Pain Threshold; Rats, Sprague-Dawley; Somatostatin; Spinal Cord; Stifle; Substance P | 2017 |
Association between sensitisation and pain-related behaviours in an experimental canine model of osteoarthritis.
Topics: Analgesics; Animals; Behavior, Animal; Diphosphonates; Dogs; Osteoarthritis; Pain; Pain Measurement; Pain Threshold; Prealbumin; Spinal Cord; Substance P | 2014 |
Changes in peptidergic fiber density in the synovium of mice with collagenase-induced acute arthritis.
Topics: Animals; Arthritis; Calcitonin Gene-Related Peptide; Collagenases; Knee Joint; Male; Mice; Mice, Inbred C57BL; Nerve Fibers; Osteoarthritis; Substance P; Synovial Membrane | 2015 |
Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue.
Topics: Arthritis, Rheumatoid; Chronic Pain; Connective Tissue; Female; Humans; Inflammation; Male; Middle Aged; Osteoarthritis; Substance P; Synovial Fluid; Synovial Membrane | 2015 |
Therapeutic effects of neuropeptide substance P coupled with self-assembled peptide nanofibers on the progression of osteoarthritis in a rat model.
Topics: Amino Acid Sequence; Animals; Disease Models, Animal; Disease Progression; In Situ Nick-End Labeling; Molecular Sequence Data; Nanofibers; Osteoarthritis; Rats; Real-Time Polymerase Chain Reaction; Substance P; X-Ray Microtomography | 2016 |
Correlation between neuropeptide distribution, cancellous bone microstructure and joint pain in postmenopausal women with osteoarthritis and osteoporosis.
Topics: Aged; Arthralgia; Calcitonin Gene-Related Peptide; Cancellous Bone; Female; Humans; Middle Aged; Neuropeptide Y; Neuropeptides; Osteoarthritis; Osteoporosis, Postmenopausal; Pain Measurement; Pain Perception; Postmenopause; Substance P; Vasoactive Intestinal Peptide | 2016 |
Marked loss of sympathetic nerve fibers in chronic Charcot foot of diabetic origin compared to ankle joint osteoarthritis.
Topics: Adrenergic Fibers; Aged; Ankle Joint; Arthrodesis; Arthropathy, Neurogenic; Diabetic Foot; Female; Foot Bones; Humans; Male; Middle Aged; Osteoarthritis; Semaphorins; Sensory Receptor Cells; Skin; Substance P; Sympathetic Nervous System; Synovial Membrane | 2009 |
Determination of specific neuropeptides modulation time course in a rat model of osteoarthritis pain by liquid chromatography ion trap mass spectrometry.
Topics: Animals; Calcitonin Gene-Related Peptide; Chromatography, Liquid; Disease Models, Animal; Dynorphins; Enzyme Inhibitors; Humans; Iodoacetic Acid; Knee Joint; Male; Neuropeptides; Osteoarthritis; Pain; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P; Tandem Mass Spectrometry; Time Factors | 2011 |
Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis.
Topics: Animals; Arthritis, Experimental; Calcitonin Gene-Related Peptide; Cartilage, Articular; Cysteine Proteinase Inhibitors; Female; Ganglia, Spinal; Knee Joint; Leupeptins; Matrix Metalloproteinase 3; Osteoarthritis; Pain; Pain Measurement; Rats; Rats, Inbred Lew; Substance P | 2012 |
Antinociceptive effects of eugenol evaluated in a monoiodoacetate-induced osteoarthritis rat model.
Topics: Analgesics; Animals; Calcitonin Gene-Related Peptide; Clove Oil; Disease Models, Animal; Dynorphins; Eugenol; Gait; Hyperalgesia; Iodoacetic Acid; Knee Joint; Male; Osteoarthritis; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 2012 |
Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint.
Topics: Adolescent; Adult; Aged; Arthralgia; Bradykinin; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Facial Pain; Female; Humans; Inflammation Mediators; Joint Dislocations; Leukotriene B4; Male; Middle Aged; Neurotransmitter Agents; Nociceptors; Osteoarthritis; Serotonin; Statistics, Nonparametric; Substance P; Synovial Fluid; Synovitis; Temporomandibular Joint Disorders | 2002 |
Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoart
Topics: Aged; Arthritis, Rheumatoid; Calcitonin Gene-Related Peptide; Cytokines; Dose-Response Relationship, Drug; Female; Humans; Interleukin-1; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Neuropeptide Y; Osteoarthritis; Peptides; Substance P; Tumor Necrosis Factor-alpha; Vasoactive Intestinal Peptide | 2003 |
Acupuncture treatment for musculoskeletal chest pain.
Topics: Acupuncture Therapy; Chest Pain; Fibromyalgia; Humans; Keratan Sulfate; Osteoarthritis; Serotonin; Substance P | 2007 |
Prognostic factors in arthrocentesis of the temporomandibular joint: Comparison of bradykinin, leukotriene B4, prostaglandin E2, and substance P level in synovial fluid between successful and unsuccessful cases.
Topics: Adolescent; Adult; Aged; Bradykinin; Dinoprostone; Female; Humans; Joint Dislocations; Leukotriene B4; Male; Middle Aged; Osteoarthritis; Pain; Paracentesis; Prognosis; Statistics, Nonparametric; Substance P; Synovial Fluid; Temporomandibular Joint Disorders | 2007 |
Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes.
Topics: Adult; Arthritis, Rheumatoid; Cartilage, Articular; Cells, Cultured; Chondrocytes; Extracellular Matrix; Fibroblast Growth Factor 2; Humans; Interleukin-1beta; Matrix Metalloproteinase 13; Matrix Metalloproteinases; Metabolism; Mitogen-Activated Protein Kinases; Neurosecretory Systems; NF-kappa B; Osteoarthritis; Proteoglycans; raf Kinases; Receptors, Neurokinin-1; Signal Transduction; Substance P; Synovial Fluid; Time Factors; Up-Regulation | 2008 |
Neuropeptides and interleukin-6 in human joint inflammation relationship between intraarticular substance P and interleukin-6 concentrations.
Topics: Arthritis, Rheumatoid; Female; Humans; Immunoenzyme Techniques; Interleukin-6; Knee Joint; Male; Middle Aged; Neuropeptides; Osmolar Concentration; Osteoarthritis; Radioimmunoassay; Substance P | 1994 |
Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis.
Topics: Adult; Aged; Arthritis; Arthritis, Psoriatic; Arthritis, Rheumatoid; Calcitonin Gene-Related Peptide; Female; Humans; Male; Middle Aged; Neurokinin A; Neuropeptide Y; Osteoarthritis; Regression Analysis; Spondylitis, Ankylosing; Substance P; Synovial Fluid; Temporomandibular Joint Disorders | 1995 |
Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Calcitonin Gene-Related Peptide; Female; Gout; Humans; Male; Middle Aged; Osteoarthritis; Radioimmunoassay; Substance P; Synovial Fluid; Vasoactive Intestinal Peptide | 1993 |
Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Humans; Middle Aged; Osteoarthritis; Radioimmunoassay; Substance P; Synovial Fluid; Synovial Membrane | 1993 |
Substance P level in synovial fluid may predict pain relief after knee replacement.
Topics: Aged; Aged, 80 and over; Female; Humans; Knee Prosthesis; Male; Middle Aged; Osteoarthritis; Pain, Postoperative; Prognosis; Substance P; Synovial Fluid | 1997 |
Distributional changes in substance P nociceptive fiber patterns in naturally osteoarthritic articulations.
Topics: Animals; Cartilage, Articular; Horses; Immunohistochemistry; Metacarpophalangeal Joint; Nociceptors; Osteoarthritis; Pain; Radiography; Substance P | 1997 |
Neuropeptides and human osteoarthritis.
Topics: Aged; Chondrocytes; Dipeptidyl Peptidase 4; Enkephalin, Methionine; Flow Cytometry; Gastrin-Releasing Peptide; Humans; Immunohistochemistry; Middle Aged; Neprilysin; Neurotransmitter Agents; Osteoarthritis; Substance P | 1998 |
Concentrations of substance P and prostaglandin E2 in synovial fluid of normal and abnormal joints of horses.
Topics: Animals; Dinoprostone; Female; Horse Diseases; Horses; Joint Diseases; Male; Osteoarthritis; Radiography; Radioimmunoassay; Statistics, Nonparametric; Substance P; Synovial Fluid | 2000 |
The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Chronic Disease; Cytokines; Electric Stimulation; Humans; Knee Joint; Macrophages; Middle Aged; Nerve Fibers; Norepinephrine; Osteoarthritis; Sensory Receptor Cells; Substance P; Sympathetic Nervous System; Synovial Membrane | 2000 |
Production of neuropeptide substance P by synovial fibroblasts from patients with rheumatoid arthritis and osteoarthritis.
Topics: Arthritis, Rheumatoid; Cells, Cultured; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Fibroblasts; Humans; Immunohistochemistry; Nerve Fibers; Osteoarthritis; Protein Precursors; RNA, Messenger; Substance P; Synovial Membrane; Tachykinins; Transforming Growth Factor beta | 2001 |
The influence of experimentally induced osteoarthrosis on articular nerve fibers of the sheep temporomandibular joint.
Topics: Analysis of Variance; Animals; Autonomic Nervous System; Calcitonin Gene-Related Peptide; Cicatrix; Cysts; Disease Models, Animal; Fibrosis; Image Processing, Computer-Assisted; Immunohistochemistry; Joint Capsule; Male; Mandibular Condyle; Nerve Fibers; Nerve Tissue Proteins; Neurons, Afferent; Neuropeptide Y; Osteoarthritis; Sheep; Statistics, Nonparametric; Substance P; Synovial Membrane; Temporomandibular Joint; Temporomandibular Joint Disc; Temporomandibular Joint Disorders; Thiolester Hydrolases; Tyrosine 3-Monooxygenase; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 2001 |
Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis.
Topics: Adrenergic Fibers; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Biomarkers; Cell Count; Cells, Cultured; Humans; Interleukin-6; Interleukin-8; Matrix Metalloproteinase 3; Middle Aged; Norepinephrine; Osteoarthritis; Predictive Value of Tests; Substance P; Synovial Membrane; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2002 |
Substance P and arthritis: analysis of plasma and synovial fluid levels.
Topics: Arthritis; Arthritis, Reactive; Arthritis, Rheumatoid; Humans; Joints; Osteoarthritis; Substance P; Synovial Fluid; Wounds and Injuries | 1990 |
Effect of capsaicin on the release of substance P from rheumatoid arthritis and osteoarthritis synoviocytes in vitro.
Topics: Arthritis, Rheumatoid; Capsaicin; Humans; Osteoarthritis; Substance P; Synovial Fluid | 1990 |
Concentrations of neuropeptides substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. A correlation with symptoms, signs and arthroscopic fi
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Arthroscopy; Calcitonin Gene-Related Peptide; Cartilage, Articular; Female; Humans; Male; Middle Aged; Neurokinin A; Neuropeptide Y; Neuropeptides; Osteoarthritis; Substance P; Synovial Fluid; Synovitis; Temporomandibular Joint; Temporomandibular Joint Disorders; Vasoactive Intestinal Peptide | 1991 |
Substance P and somatostatin levels in rheumatoid arthritis, osteoarthritis, and psoriatic arthritis synovial fluid.
Topics: Arthritis; Arthritis, Rheumatoid; Humans; Osteoarthritis; Psoriasis; Somatostatin; Substance P; Synovial Fluid | 1991 |
Periosteal and vascular innervation of the human patella in degenerative joint disease.
Topics: Adult; Aged; Aged, 80 and over; Capillaries; Cartilage; Cartilage Diseases; Female; Humans; Immunohistochemistry; Male; Middle Aged; Osteoarthritis; Patella; Periosteum; Serotonin; Substance P | 1989 |